{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T16:12:59Z","timestamp":1769098379568,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thrombosis J"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Dengue virus infected patients have high plasminogen activator inhibitor type I (PAI-1) plasma concentrations. Whether the insertion\/deletion (4G\/5G) polymorphism in the promotor region of the PAI-1 gene is associated with increased PAI-1 plasma concentrations and with death from dengue is unknown. We, therefore, investigated the relationship between the 4G\/5G polymorphism and PAI-1 plasma concentrations in dengue patients and risk of death from dengue.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A total of 194 patients admitted to the Dr. Kariadi Hospital in Semarang, Indonesia, with clinical suspected severe dengue virus infection were enrolled. Blood samples were obtained on day of admission, days 1, 2 and 7 after admission and at a 1-month follow-up visit. Plasma concentrations of PAI-1 were measured using a sandwich ELISA kit. The PAI-1 4G\/5G polymorphism was typed by allele-specific PCR analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Concentrations of PAI-1 on admission and peak values of PAI-1 during admission were higher than the values measured in healthy controls. Survival was significantly worse in patients with PAI-1 concentrations in the highest tertile (at admission: OR 4.7 [95% CI 0.9\u201323.8], peak value during admission: OR 6.3 [95%CI 1.3\u201330.8]). No association was found between the PAI-1 4G\/5G polymorphism, and PAI-1 plasma concentrations, dengue disease severity and mortality from dengue.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>These data suggest that the 4G\/5G polymorphism has no significant influence on PAI-1 concentrations in dengue virus infected patients and is not associated with the risk of death from dengue. Other factors contributing to the variability of PAI-1 plasma concentrations in patients with dengue need to be explored.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1477-9560-3-17","type":"journal-article","created":{"date-parts":[[2005,11,8]],"date-time":"2005-11-08T07:16:31Z","timestamp":1131434191000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Increased PAI-1 plasma levels and risk of death from dengue: no association with the 4G\/5G promoter polymorphism"],"prefix":"10.1186","volume":"3","author":[{"given":"ATA","family":"Mairuhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TE","family":"Setiati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Koraka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CE","family":"Hack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Leyte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SMH","family":"Faradz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"ten Cate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DPM","family":"Brandjes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ADME","family":"Osterhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PH","family":"Reitsma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ECM","family":"van Gorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,11,7]]},"reference":[{"key":"36_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(97)12483-7","volume":"352","author":"JG Rigau-Perez","year":"1998","unstructured":"Rigau-Perez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, Vorndam AV: Dengue and dengue haemorrhagic fever. Lancet 1998, 352: 971-977. 10.1016\/S0140-6736(97)12483-7","journal-title":"Lancet"},{"key":"36_CR2","unstructured":"Dengue Haemorrhagic Fever: Diagnosis, treatment, prevention and control 2nd edition. World Health Organisation; 1997."},{"key":"36_CR3","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/S0140-6736(02)09964-6","volume":"360","author":"S Hales","year":"2002","unstructured":"Hales S, de Wet N, Maindonald J, Woodward A: Potential effect of population and climate changes on global distribution of dengue fever: an empirical model. Lancet 2002, 360: 830-834. 10.1016\/S0140-6736(02)09964-6","journal-title":"Lancet"},{"key":"36_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S1473-3099(03)00487-0","volume":"3","author":"AT Mairuhu","year":"2003","unstructured":"Mairuhu AT, Mac Gillavry MR, Setiati TE, Soemantri A, ten Cate H, Brandjes DP, van Gorp EC: Is clinical outcome of dengue-virus infections influenced by coagulation and fibrinolysis? A critical review of the evidence. Lancet Infect Dis 2003, 3: 33-41. 10.1016\/S1473-3099(03)00487-0","journal-title":"Lancet Infect Dis"},{"key":"36_CR5","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1046\/j.1365-2141.2001.02710.x","volume":"113","author":"EC van Gorp","year":"2001","unstructured":"van Gorp EC, Minnema MC, Suharti C, Mairuhu AT, Brandjes DP, ten Cate H, Hack CE, Meijers JC: Activation of coagulation factor XI, without detectable contact activation in dengue haemorrhagic fever. Br J Haematol 2001, 113: 94-99. 10.1046\/j.1365-2141.2001.02710.x","journal-title":"Br J Haematol"},{"key":"36_CR6","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/jmv.10137","volume":"67","author":"EC van Gorp","year":"2002","unstructured":"van Gorp EC, Setiati TE, Mairuhu AT, Suharti C, Cate HH, Dolmans WM, van der Meer JW, Hack CE, Brandjes DP: Impaired fibrinolysis in the pathogenesis of dengue hemorrhagic fever. J Med Virol 2002, 67: 549-554. 10.1002\/jmv.10137","journal-title":"J Med Virol"},{"key":"36_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1086\/341410","volume":"35","author":"BA Wills","year":"2002","unstructured":"Wills BA, Oragui EE, Stephens AC, Daramola OA, Dung NM, Loan HT, Chau NV, Chambers M, Stepniewska K, Farrar JJ, Levin M: Coagulation Abnormalities in Dengue Hemorrhagic Fever: Serial Investigations in 167 Vietnamese Children with Dengue Shock Syndrome. Clin Infect Dis 2002, 35: 277-285. 10.1086\/341410","journal-title":"Clin Infect Dis"},{"key":"36_CR8","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S0140-6736(99)02220-5","volume":"354","author":"PW Hermans","year":"1999","unstructured":"Hermans PW, Hibberd ML, Booy R, Daramola O, Hazelzet JA, de Groot R, Levin M: 4G\/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group. Lancet 1999, 354: 556-560. 10.1016\/S0140-6736(99)02220-5","journal-title":"Lancet"},{"key":"36_CR9","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S0140-6736(98)09376-3","volume":"354","author":"RG Westendorp","year":"1999","unstructured":"Westendorp RG, Hottenga JJ, Slagboom PE: Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock. Lancet 1999, 354: 561-563. 10.1016\/S0140-6736(98)09376-3","journal-title":"Lancet"},{"key":"36_CR10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-0038-1647480","volume":"65","author":"JP de Boer","year":"1991","unstructured":"de Boer JP, Abbink JJ, Brouwer MC, Meijer C, Roem D, Voorn GP, Lambers JW, van Mourik JA, Hack CE: PAI-1 synthesis in the human hepatoma cell line HepG2 is increased by cytokines--evidence that the liver contributes to acute phase behaviour of PAI-1. Thromb Haemost 1991, 65: 181-185.","journal-title":"Thromb Haemost"},{"key":"36_CR11","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1055\/s-0038-1649875","volume":"74","author":"MW Mansfield","year":"1995","unstructured":"Mansfield MW, Stickland MH, Grant PJ: Plasminogen activator inhibitor-1 (PAI-1) promoter polymorphism and coronary artery disease in non-insulin-dependent diabetes. Thromb Haemost 1995, 74: 1032-1034.","journal-title":"Thromb Haemost"},{"key":"36_CR12","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1128\/CDLI.7.6.867-871.2000","volume":"7","author":"J Groen","year":"2000","unstructured":"Groen J, Koraka P, Velzing J, Copra C, Osterhaus AD: Evaluation of six immunoassays for detection of dengue virus-specific immunoglobulin M and G antibodies. Clin Diagn Lab Immunol 2000, 7: 867-871. 10.1128\/CDLI.7.6.867-871.2000","journal-title":"Clin Diagn Lab Immunol"},{"key":"36_CR13","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1128\/JCM.41.9.4154-4159.2003","volume":"41","author":"P Koraka","year":"2003","unstructured":"Koraka P, Burghoorn-Maas CP, Falconar A, Setiati TE, Djamiatun K, Groen J, Osterhaus AD: Detection of immune-complex-dissociated nonstructural-1 antigen in patients with acute dengue virus infections. J Clin Microbiol 2003, 41: 4154-4159. 10.1128\/JCM.41.9.4154-4159.2003","journal-title":"J Clin Microbiol"},{"key":"36_CR14","first-page":"431","volume":"22","author":"H Passing","year":"1984","unstructured":"Passing H, Bablok W: Comparison of several regression procedures for method comparison studies and determination of sample sizes. Application of linear regression procedures for method comparison studies in Clinical Chemistry, Part II. J Clin Chem Clin Biochem 1984, 22: 431-445.","journal-title":"J Clin Chem Clin Biochem"},{"key":"36_CR15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/clinchem\/40.1.110","volume":"40","author":"P Meijer","year":"1994","unstructured":"Meijer P, Pollet DE, Wauters J, Kluft C: Specificity of antigen assays of plasminogen activator inhibitor in plasma: Innotest PAI-1 immunoassay evaluated. Clin Chem 1994, 40: 110-115.","journal-title":"Clin Chem"},{"key":"36_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0049-3848(90)90326-8","volume":"57","author":"P Brandtzaeg","year":"1990","unstructured":"Brandtzaeg P, Joo GB, Brusletto B, Kierulf P: Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease. Thromb Res 1990, 57: 271-278. 10.1016\/0049-3848(90)90326-8","journal-title":"Thromb Res"},{"key":"36_CR17","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1093\/infdis\/173.5.1148","volume":"173","author":"RF Kornelisse","year":"1996","unstructured":"Kornelisse RF, Hazelzet JA, Savelkoul HF, Hop WC, Suur MH, Borsboom AN, Risseeuw-Appel IM, van V, de Groot R: The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock. J Infect Dis 1996, 173: 1148-1156.","journal-title":"J Infect Dis"},{"key":"36_CR18","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1055\/s-0038-1650392","volume":"75","author":"RM Mesters","year":"1996","unstructured":"Mesters RM, Florke N, Ostermann H, Kienast J: Increase of plasminogen activator inhibitor levels predicts outcome of leukocytopenic patients with sepsis. Thromb Haemost 1996, 75: 902-907.","journal-title":"Thromb Haemost"},{"key":"36_CR19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0038-1647143","volume":"64","author":"JA Paramo","year":"1990","unstructured":"Paramo JA, Perez JL, Serrano M, Rocha E: Types 1 and 2 plasminogen activator inhibitor and tumor necrosis factor alpha in patients with sepsis. Thromb Haemost 1990, 64: 3-6.","journal-title":"Thromb Haemost"},{"key":"36_CR20","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1055\/s-0038-1646614","volume":"61","author":"G Pralong","year":"1989","unstructured":"Pralong G, Calandra T, Glauser MP, Schellekens J, Verhoef J, Bachmann F, Kruithof EK: Plasminogen activator inhibitor 1: a new prognostic marker in septic shock. Thromb Haemost 1989, 61: 459-462.","journal-title":"Thromb Haemost"},{"key":"36_CR21","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1182\/blood.V64.4.907.907","volume":"64","author":"EK Kruithof","year":"1984","unstructured":"Kruithof EK, Tran-Thang C, Ransijn A, Bachmann F: Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma. Blood 1984, 64: 907-913.","journal-title":"Blood"},{"key":"36_CR22","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1002\/j.1460-2075.1986.tb04532.x","volume":"5","author":"H Pannekoek","year":"1986","unstructured":"Pannekoek H, Veerman H, Lambers H, Diergaarde P, Verweij CL, van Zonneveld AJ, van Mourik JA: Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family. EMBO J 1986, 5: 2539-2544.","journal-title":"EMBO J"},{"key":"36_CR23","doi-asserted-by":"crossref","first-page":"10739","DOI":"10.1016\/S0021-9258(18)82047-6","volume":"268","author":"SJ Dawson","year":"1993","unstructured":"Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Henney AM: The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 1993, 268: 10739-10745.","journal-title":"J Biol Chem"},{"key":"36_CR24","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1042\/bj3141041","volume":"314 ( Pt 3)","author":"MP Ryan","year":"1996","unstructured":"Ryan MP, Kutz SM, Higgins PJ: Complex regulation of plasminogen activator inhibitor type-1 (PAI-1) gene expression by serum and substrate adhesion. Biochem J 1996, 314 ( Pt 3): 1041-1046.","journal-title":"Biochem J"},{"key":"36_CR25","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1086\/517807","volume":"177","author":"DB Bethell","year":"1998","unstructured":"Bethell DB, Flobbe K, Cao XT, Day NP, Pham TP, Buurman WA, Cardosa MJ, White NJ, Kwiatkowski D: Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. J Infect Dis 1998, 177: 778-782.","journal-title":"J Infect Dis"},{"key":"36_CR26","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1086\/314680","volume":"179","author":"S Green","year":"1999","unstructured":"Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, Nisalak A, Lew R, Innis BL, Kurane I, Rothman AL, Ennis FA: Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis 1999, 179: 755-762. 10.1086\/314680","journal-title":"J Infect Dis"},{"key":"36_CR27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1086\/380762","volume":"189","author":"TH Nguyen","year":"2004","unstructured":"Nguyen TH, Lei HY, Nguyen TL, Lin YS, Huang KJ, Le BL, Lin CF, Yeh TM, Do QH, Vu TQ, Chen LC, Huang JH, Lam TM, Liu CC, Halstead SB: Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J Infect Dis 2004, 189: 221-232. 10.1086\/380762","journal-title":"J Infect Dis"},{"key":"36_CR28","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1073\/pnas.92.6.1851","volume":"92","author":"P Eriksson","year":"1995","unstructured":"Eriksson P, Kallin B, 't Hooft FM, Bavenholm P, Hamsten A: Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci U S A 1995, 92: 1851-1855.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"36_CR29","first-page":"109","volume":"117","author":"LR Wing","year":"1991","unstructured":"Wing LR, Hawksworth GM, Bennett B, Booth NA: Clearance of t-PA, PAI-1, and t-PA-PAI-1 complex in an isolated perfused rat liver system. J Lab Clin Med 1991, 117: 109-114.","journal-title":"J Lab Clin Med"},{"key":"36_CR30","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1600-0676.1998.tb00148.x","volume":"18","author":"T Hayashi","year":"1998","unstructured":"Hayashi T, Kamogawa A, Ro S, Yamaguchi K, Kobayashi Y, Takahashi Y, Murayama M: Plasma from patients with cirrhosis increases tissue plasminogen activator release from vascular endothelial cells in vitro. Liver 1998, 18: 186-190.","journal-title":"Liver"},{"key":"36_CR31","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1055\/s-0038-1646877","volume":"62","author":"C Tran-Thang","year":"1989","unstructured":"Tran-Thang C, Fasel-Felley J, Pralong G, Hofstetter JR, Bachmann F, Kruithof EK: Plasminogen activators and plasminogen activator inhibitors in liver deficiencies caused by chronic alcoholism or infectious hepatitis. Thromb Haemost 1989, 62: 651-653.","journal-title":"Thromb Haemost"},{"key":"36_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/tropej\/46.1.40","volume":"46","author":"B Mohan","year":"2000","unstructured":"Mohan B, Patwari AK, Anand VK: Hepatic dysfunction in childhood dengue infection. J Trop Pediatr 2000, 46: 40-43. 10.1093\/tropej\/46.1.40","journal-title":"J Trop Pediatr"},{"key":"36_CR33","first-page":"S298","volume":"85 Suppl 1","author":"C Pancharoen","year":"2002","unstructured":"Pancharoen C, Rungsarannont A, Thisyakorn U: Hepatic dysfunction in dengue patients with various severity. J Med Assoc Thai 2002, 85 Suppl 1: S298-S301.","journal-title":"J Med Assoc Thai"},{"key":"36_CR34","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1590\/S1413-86702004000200006","volume":"8","author":"LJ Souza","year":"2004","unstructured":"Souza LJ, Alves JG, Nogueira RM, Gicovate NC, Bastos DA, Siqueira EW, Souto Filho JT, Cezario TA, Soares CE, Carneiro RC: Aminotransferase changes and acute hepatitis in patients with dengue fever: analysis of 1,585 cases. Braz J Infect Dis 2004, 8: 156-163.","journal-title":"Braz J Infect Dis"},{"key":"36_CR35","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1161\/01.CIR.0000066908.82782.3A","volume":"107","author":"A Festa","year":"2003","unstructured":"Festa A, D'Agostino RJ, Rich SS, Jenny NS, Tracy RP, Haffner SM: Promoter (4G\/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Circulation 2003, 107: 2422-2427. 10.1161\/01.CIR.0000066908.82782.3A","journal-title":"Circulation"},{"key":"36_CR36","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1161\/01.ATV.17.5.851","volume":"17","author":"M Henry","year":"1997","unstructured":"Henry M, Chomiki N, Scarabin PY, Alessi MC, Peiretti F, Arveiler D, Ferrieres J, Evans A, Amouyel P, Poirier O, Cambien F, Juhan-Vague I: Five frequent polymorphisms of the PAI-1 gene: lack of association between genotypes, PAI activity, and triglyceride levels in a healthy population. Arterioscler Thromb Vasc Biol 1997, 17: 851-858.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"36_CR37","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1161\/01.ATV.18.1.84","volume":"18","author":"M Henry","year":"1998","unstructured":"Henry M, Tregouet DA, Alessi MC, Aillaud MF, Visvikis S, Siest G, Tiret L, Juhan-Vague I: Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas Cohort. Arterioscler Thromb Vasc Biol 1998, 18: 84-91.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"36_CR38","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1055\/s-0038-1649834","volume":"74","author":"MW Mansfield","year":"1995","unstructured":"Mansfield MW, Stickland MH, Grant PJ: Environmental and genetic factors in relation to elevated circulating levels of plasminogen activator inhibitor-1 in Caucasian patients with non-insulin-dependent diabetes mellitus. Thromb Haemost 1995, 74: 842-847.","journal-title":"Thromb Haemost"}],"container-title":["Thrombosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-9560-3-17.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T07:10:02Z","timestamp":1630480202000},"score":1,"resource":{"primary":{"URL":"https:\/\/thrombosisjournal.biomedcentral.com\/articles\/10.1186\/1477-9560-3-17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,7]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["36"],"URL":"https:\/\/doi.org\/10.1186\/1477-9560-3-17","relation":{},"ISSN":["1477-9560"],"issn-type":[{"value":"1477-9560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,7]]},"assertion":[{"value":"17 March 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"17"}}